Literature DB >> 3153218

Acute encephalopathy during induction therapy for acute lymphoblastic leukemia.

M P Gerrard1, O B Eden, J S Lilleyman.   

Abstract

Twenty-one children who suffered an acute encephalopathic illness during induction chemotherapy for ALL are described. Convulsions and coma were a major feature of this illness. In the absence of other predisposing factors we feel that the encephalopathy was secondary to drug toxicity. Two children died, and 4 of the surviving children have also died. Modifications of antileukemic therapy because of encephalopathic illness may have had a part to play in the outcome for some of these children. The surviving children appear to be neurologically and developmentally normal.

Entities:  

Mesh:

Year:  1986        PMID: 3153218     DOI: 10.3109/08880018609031200

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

1.  Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.

Authors:  Stephanie L Nassar; Heather M Conklin; Yinmei Zhou; Jason M Ashford; Wilburn E Reddick; John O Glass; Fred H Laningham; Sima Jeha; Cheng Cheng; Ching-Hon Pui
Journal:  Pediatr Blood Cancer       Date:  2017-01-28       Impact factor: 3.167

2.  Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment.

Authors:  L Vainionpää
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

3.  Neurological complications of acute childhood leukaemia.

Authors:  J S Lilleyman
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.